Guidelines for the Management of Cytomegalovirus Infection in Patients With Hematological Malignancies and After Stem Cell Transplantation from the 2017 European Conference on Infections in Leukemia (ECIL 7)

This is a clinical practice guideline for patients who have undergone hematopoietic stem cell transplantation (HSCT), and/or those who are receiving other types of therapy for hematological malignancies. The guideline examines the prevention, diagnosis, and management of cytomegalovirus (CMV) infection in these patients. The primary outcomes of interest are CMV serostatus and survival.